Self-Learning and Non-Invasive Bladder Monitoring Systems and Methods
US-2024081708-A1 · Mar 14, 2024 · US
US2023355181A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023355181-A1 |
| Application number | US-202318222739-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 17, 2023 |
| Priority date | Nov 4, 2008 |
| Publication date | Nov 9, 2023 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An insulin infusion device includes a cannula for infusing insulin under the skin and an insulin infusion section for storing therein insulin to be delivered to the cannula. The insulin infusion device also includes a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity. The insulin infusion device also includes a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section.
Opening claim text (preview).
What is claimed is: 1 . An insulin infusion device comprising: a cannula for infusing insulin under the skin; an insulin infusion section for storing therein insulin to be delivered to the cannula; a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity; and a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section. 2 . The insulin infusion device according to claim 1 , further comprising a recording section that records therein the motion information. 3 . The insulin infusion device according to claim 2 , further comprising a communication section that transmits the motion information recorded in the recording section. 4 . The insulin infusion device according to claim 2 , further comprising a display section that displays thereon the motion information recorded in the recording section. 5 . The insulin infusion device according to claim 1 , further comprising: a biosensor which selectively responds to a specific analyte in a biological fluid for detecting the presence or concentration of the analyte in the biological fluid; an analyte measurement section that measures a characteristic amount of the analyte with the biosensor; and a recording section that records therein the motion information and the characteristic amount with the motion information and the characteristic amount associated with each other. 6 . The insulin infusion device according to claim 5 , wherein the biosensor is a continuous glucose monitoring sensor to be inserted under the skin. 7 . The insulin infusion device according to claim 5 , wherein the biosensor is a blood glucose sensor for measuring blood glucose level. 8 . The insulin infusion device according to claim 1 , further comprising a pump section for delivering insulin stored in the insulin infusion section to the cannula, wherein the controlling section estimates, based the operation time of the pump section, the quantity of insulin being delivered by continuous subcutaneous insulin infusion or the quantity of the last bolus that is still active in the body (insulin on board), and records the estimated quantity in the recording section. 9 . The insulin infusion device according to claim 1 , further comprising a living activity calculation section that calculates, based on the motion information, living activity level in terms of METs.
using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured · CPC title
characterised by the type of physiological signal transmitted · CPC title
for measuring glucose, e.g. by tissue impedance measurement · CPC title
using enzyme electrodes, e.g. with immobilised oxidase · CPC title
invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.